Navigation Links
Savient Closes Sale of $230 Million in Convertible Senior Notes
Date:2/4/2011

e SEC Web site at www.sec.gov.  Alternatively, copies of the prospectus meeting the requirements of Section 10 of the Securities Act of 1933 may be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717; Telephone (631) 254-1735.

About Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA™ (pegloticase), which was approved by the FDA on September 14, 2010 for the treatment of chronic gout in adult patients refractory to conventional therapy.

Safe Harbor Statement

This press release contains forward-looking statements, including statements about future business prospects, KRYSTEXXA™ and the offering, that are intended to be covered by the safe harbor provisions of the Securities Act of 1933 and the Securities Exchange Act of 1934.  Any statements that are not statements of historical fact (including statements containing the words "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "may," "predict," "will," and "would," and similar expressions) should be considered to be forward-looking statements. There are a number of important factors that could cause actual results to differ materially from those indicated in any forward-looking statements made by Savient, including the factors described in Savient's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, which has been filed with the Securities and Exchange Commission.

SVNT - I


'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... WHITEHOUSE STATION, N.J. , Sept. 19, 2014 Merck ... the United States and Canada , ... on Desafiando La Diabetes: Logra Tus Metas , an educational ... of their blood sugar -- a key treatment goal to help ... the United States are at a higher risk for ...
(Date:9/19/2014)... Sept. 19, 2014 Five MinuteClinic walk-in medical clinics are ... metropolitan area. Three clinics opened in Memphis ... fourth clinic will be added in Springfield ... is expected to open October 22.  MinuteClinic is the ... the United States . The ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
(Date:9/19/2014)... The Alliance for Bangladesh Worker Safety ... Fire Protection Association (NFPA), a recognized international leader ... a Memorandum of Understanding signed by both organizations, ... stakeholders with information, guidance and access to training ... safety of workers in ready-made garment (RMG) factories ...
(Date:9/19/2014)... Pittsburgh, PA (PRWEB) September 19, 2014 ... I fear getting wrinkles due to stretching the skin ... from Anniston, Ala. "This inspired me to design a ... HANDS-FREE EYE CONTACT LENS SYSTEM provides a quicker, easier, ... eliminates the need to perform this task manually, saves ...
(Date:9/19/2014)... -- Recent two-generation approaches to reducing poverty that ... attention from researchers, advocates, and foundations. By combining ... to move to jobs that offer a path ... education for children, these programs aim to improve ... to a new report from the National Center ...
(Date:9/19/2014)... When it comes to firearm deaths, Hawaii has the ... District of Columbia has the highest, according to new ... violence -- including murders, suicides and unintentional shootings -- ... Hawaii,s rate was roughly three per 100,000 citizens. On ... Columbia had the highest rate of gun deaths, with ...
(Date:9/19/2014)... by Medical College of Wisconsin (MCW) scientists has identified a ... rats, mice and in humans. The findings are published in ... , Leah Solberg Woods, Ph.D., associate professor of pediatrics at ... Research Institute, led the study and is the corresponding author ... a gene called Tpcn2 in which a variant was associated ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2
... in French . , Montreal, August 27, 2010 ... against the blues, scientists at the University of Toronto and ... increase depressive symptoms in some adolescents. Published in the journal ... long-term Nicotine Dependence in Teens (NDIT) study based at the ...
... Mothers who did not breastfeed their children have significantly higher ... who breastfed , report University of Pittsburgh researchers in a ... of Medicine. "We have seen dramatic increases ... century," said Eleanor Bimla Schwarz, M.D., M.S., assistant professor of ...
... a wily, familiar bacterium, causes a growing number of ... $7.5 million, five-year award from the National Institutes of Health, ... the microbe and in patients make C. difficile ... a half-million Americans each year. ,U-M scientists and clinicians from ...
... HealthDay Reporter , THURSDAY, Aug. 26 (HealthDay News) -- ... every single day. You have aches and pains, difficulty ... energy. You take fistfuls of medication for relief and ... progressing. The illness might be physical, such as ...
... one-day conference on the "Future of independent academic clinical ... auspices of the Belgian Presidency of the European Union ... in Brussels. The Royal Academies of Medicine ... for Investigator Driven Clinical Trials (ICDT) because the current ...
... of using thermal ablation to target and kill cancer ... and Interventional Radiology ,s August supplement, "Thermal Ablation 2010: ... Future Technology." "The Journal of Vascular ... development of multiple medical techniques and devices for cancer ...
Cached Medicine News:Health News:Smoking increases depressive symptoms in teens 2Health News:U-M launches effort to conquer common hospital-acquired infection 2Health News:Does Hope Have a Dark Side? 2Health News:Does Hope Have a Dark Side? 3Health News:Journal of Vascular and Interventional Radiology sees growth, promise of tumor ablation 2
VersaStep™ Reposable Sterilization Trays....
... device is comprised of the following components. ... port are also packaged in the following ... with 12 mm Step™ cannula assembly and ... mm locking cone with 10/12 mm Reposable ...
... components are supplied sterile. , ,The Step™ ... sterile in 2/3, 5, 7/8, 10 and 12 ... They are used in conjunction with the Step™ ... Expandable Sleeve. The 5, 7/8, 10 and 12 ...
... VERSAPORT™ PLUS V2 RT single-use obturator has a ... , ,The Auto Suture™ VERSAPORT™ PLUS V2 ... 5-12, 11 mm and 12 mm diameters with ... and 5 mm short single-use obturators are not ...
Medicine Products: